Search

everythinglearnresearchcommunity

for

Search:↓

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

Testosterone's effects on COVID-19 are unclear and need more research.

COVID-19 can cause a temporary hair loss condition.

Low testosterone may indicate severe COVID-19 in men.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

COVID-19 may cause temporary hair loss in some people.

Targeting endolysosomes may help treat COVID-19.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

COVID-19 may cause hair loss by affecting hair follicles.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.